Lung cancer is the most common type of cancer in the world and our country, with the highest death toll. One in five deaths from cancer in both men and women is due to lung cancer. In addition to the increasing incidence due to the increase in cigarette consumption and air pollution, the incidence is constantly increasing among non-smokers due to other factors. Cancer occurs as a result of uncontrolled cell proliferation as a result of DNA damage to the cells in the lung tissue. Uncontrolled proliferation of cells can spread to all organs (metastasis), especially bone and brain, as the disease progresses.
The most important factors in the success of the treatment are the stage of the disease, the cell type, and the general condition of the patient. While complete treatment can be achieved with surgery in the early stages, the chance of success decreases in cases caught in the advanced stage.
Tobacco products are responsible for 90% of lung cancers. Passive cigarette exposure was found as a risk factor in one-third of non-smokers with lung cancer. It has been shown that it increases 23 times in men and 13 times in women who have smoked an average of one pack of cigarettes a day for at least 20 years compared to non-smokers. Although a significant risk increase in the amount of cigarette consumption is determined as an average of 20 years and 1 pack per day, the risk increases in less tobacco use due to starting to smoke at an early age, smoking at home, and occupational and genetic risk factors.
Although the risk of lung cancer begins to decrease from the moment of quitting smoking, significant risk reduction occurs after 25 years. However, this risk is always higher than for individuals who have never smoked.
It is known that the use of cigars increases the risk 3 times, and the use of pipes increases the risk 8 times. However, 'light' cigarettes with low nicotine and tar levels do not reduce the risk either.
The most important point in the prevention of lung cancer is to avoid smoking. Avoiding inhalation of all toxic agents, especially cigarettes, significantly reduces the risk of disease.
It is also very important to work with protective equipment in compulsory occupational exposures and to minimize the amount of contact with working hours and controls.
The most common symptoms of lung cancer are cough, bloody sputum, chest pain, hoarseness, unexplained weight loss, shortness of breath, new-onset wheezing, and recurrent pneumonia that is difficult to treat. Apart from these symptoms, patients may also consult a physician with complaints such as unilateral drooping of the eyelid, numbness in the arm, pain, weakness, loss of muscle strength, and head and neck edema. All these signs and symptoms may vary depending on the location and size of the tumor.
Lung cancer often spreads to the bones, brain, and adrenal glands. When it spreads to the bones, it can cause fractures that develop independently of pain and trauma. Epileptic seizures, personality changes, and vision loss can be seen in metastases developing in the brain. Tumors can cause nausea, vomiting, weakness, and clouding of consciousness by disrupting the metabolism of vital minerals such as calcium and sodium, with the spread and the substances they secrete, even outside the place where they are located.
As with all types of cancer, early diagnosis of lung cancer saves lives. Screening is recommended with annual chest radiography for smokers, those with a family history of cancer, and those in occupational groups exposed to toxic substances, and with low-dose tomography for high-risk groups over 55 years of age. In these groups, it was determined that chest tomography increases the diagnosis of lung cancer 3 times and the chance of early diagnosis 10 times.
Bronchoscopy examination is recommended for unexplained cough and recurrent pneumonia.
75-80 percent of diagnosed lung cancer cases are in advanced stages that have lost their chance for surgery. The widespread use of chest tomography in risky groups and its use in the diagnosis of lung cancer have increased the chance of early diagnosis.
If a tumor is suspected in the lung, it is necessary to perform a biopsy of the tissue. If the tumor is close to the airways, a biopsy is taken with bronchoscopy. In tumors that are thought to be inaccessible by bronchoscopy, a sample is taken from the patient's tissue by entering the thorax with biopsy needles from the outside, under the guidance of chest tomography. The definitive diagnosis is made by pathological examination of the removed tissue.
Bronchoscopy is a method of endoscopic examination of the lower respiratory tract and bronchi. The inside of the bronchus and its mucosa are observed with a light camera, and the diameter of the patient tissue, its effects on the trachea, and its vascularization are examined. A biopsy can also be taken from the lymph nodes observed in the tomography.
Another method of diagnosing lung cancer is the examination of cells in phlegm (cytology). Although tumor cells can be observed in the phlegm consisting of lower respiratory tract cells and mucous secretions, the chance of success in this examination is very low.
Lung cancer can be diagnosed with the 'liquid biopsy' method, which has recently been started to be applied in a limited number of centers in our country. Although its use and effectiveness are limited today, its prevalence will increase in the future. Thanks to this method, which makes the diagnosis by separating tumor cells in the blood and performing genetic analysis, it is also possible to follow up on the genetic changes that may develop in the tumor cell during the treatment stages.
Staging is done by identifying tumor size, lymph nodes, and distant organ metastases. PET-CT, which is based on the principle of detecting the uptake of nuclear-labeled glucose in rapidly proliferating cells, and examination of brain tissue with MRI, where the PET-CT method is insufficient, are important methods in staging.
The treatments for non-small cell lung cancer and small cell lung cancer are different. Treatment varies according to the stage of the disease.
Depending on the type and stage of lung cancer, some, or all of the options such as surgery, radiotherapy (radiation therapy), chemotherapy (treatment with medications), targeted therapy, and immunotherapy are applied in different sequences according to the characteristics of the patient and the disease.
Cancer treatment aims to eradicate the disease, if possible, to limit it, to prolong survival, and to increase the patient's quality of life. A multidisciplinary approach is very important for the best treatment of lung cancer.
The situation of each patient with lung cancer is different from each other. The use of different treatment options alone or together according to the disease and the patient's condition requires the joint work of many physicians from different departments and the determination of the most appropriate treatment for the patient with a joint decision.
In this way, the most accurate and up-to-date treatments can be applied without delay. In the multidisciplinary approach, the consensus of medical oncology, thoracic surgery, chest diseases, radiation oncology, pathology, radiology, and nuclear medicine specialists is achieved, and the help of a dietitian, psychiatrist, and pain therapist is requested when necessary.
In the early stages of lung cancer, the most effective treatment is surgery if the patient does not have any other disease that prevents surgery. Patients may refuse treatment when surgery is recommended due to false beliefs such as "Surgery is not appropriate for cancer" and "A biopsy was performed and cancer has spread".
Those who are offered surgical treatment for lung cancer constitute the group of patients whose diseases are at relatively early stages and have the highest chance of long-term disease-free survival when the cancerous tissue can be completely removed by surgery.
In fact, approximately 75-80% of lung cancer patients who apply to the physician have lost the chance of being treated with surgery.
Therefore, surgery cannot be recommended for every patient. If you have been told by your physicians that your disease was detected at an early stage before it spreads far, you need an operation and you are in a position to undergo this surgery due to your general health condition, do not miss this chance. Because it is unlikely that you will have the same chance of recovery with the treatments to be performed instead.
Saying "You can't undergo surgery" to a cancer patient is a very important decision for that patient's treatment planning and the chance of recovery.
Therefore, such an important decision should be made meticulously after a detailed examination using high technology. This, inevitably, is directly related to the technological level of the equipment and infrastructure in the institution where the examinations are carried out.
Likewise, physicians who have a share in the diagnosis and staging must have the specialization to best interpret the detailed data obtained in favor of the patient and by reaching a consensus. In Yeditepe University Hospitals, some patients, who were told that they could not have surgery, actually see that they have a chance of surgery as a result of a detailed examination, and these patients can be helped to have a higher chance of survival by performing surgical treatments along with other treatment methods.
If a definitively diagnosed lung cancer patient is found to be at the stage suitable for surgery as a result of staging, the patient should be evaluated in terms of suitability for surgery. In this respect, the patient's age, general condition, other accompanying diseases, especially cardiac and circulatory functions, and lung respiratory capacity are considered.
Advanced age alone does not prevent surgery, and the important thing is the deterioration in heart, lung, brain, and kidney functions that may increase with age. Lung function tests are performed in all patients, and heart functions are evaluated. As a result of this evaluation, the decision of surgery is given to the patients who are found suitable.
A significant portion of lung cancer patients is treated with treatment methods other than surgery since their disease has spread to a certain extent. On the other hand, in cases such as fluid or abscess accumulation around the lungs or in the pericardium, air leakage from the lungs, shortness of breath caused by disease-related obstruction and narrowing in the main trachea and bronchial branches, or bleeding from the lungs, which these patients may encounter during their treatment, there are many endoscopic and open surgical interventions that we perform in order to reduce the complaints of our patients and increase their quality of life. Again, since it is known that it is necessary to constantly insert a catheter into the veins of our patients during chemotherapy and this process becomes increasingly difficult due to the narrowing and occlusion of the veins due to medications, PORT catheters, which are hidden under the skin and placed in the main vein, are inserted in our patients in order to continue this treatment easily and without discomfort. With careful and regular use and maintenance, these PORT catheters can be used for years without any problems and provide great comfort to patients.
Chemotherapy is a medication treatment consisting of powerful chemicals used to kill fast-growing abnormal cells in your body. Chemotherapy used in medicine is used to treat many types of cancer because cancer cells grow and multiply much faster than most cells in the body. There are many different chemotherapy drugs used today, and these drugs can be administered to cancer patients alone or in combination. It is important to know that drugs used to treat cancer act differently.
Chemotherapy drugs have side effects and each drug used has different side effects. You can receive information from your doctor about the side effects of chemotherapy drugs used in your treatment, and you can receive preventive or auxiliary drug recommendations to mitigate these effects.
Cancer immunotherapy, also known as immuno-oncology, is a form of cancer treatment that uses the strength (cells) of the body's own immune system to prevent, control, and eradicate cancer.
Immunotherapy virtually trains the immune system to recognize and attack certain cancer cells. It increases the number of immune cells, or body defense cells, to help eliminate cancer cells. Additionally, it provides new components to boost the body's immune response.
Cancer immunotherapy consists of various components, and these consist of various forms such as targeted antibodies, cancer vaccines, transfer of stimulating cells to the body, tumor-infecting viruses, stopping the checkpoints of defense cells (inhibitors), and thus making them function further. Immunotherapies are a type of biotherapy (also called biological response modifying therapy) because they are also used in the form of using materials from living organisms to fight diseases.
Some immunotherapies are used by genetic engineering to improve the cancer-fighting abilities of immune cells, and these may be referred to as gene therapies. Immunotherapies are used to prevent different types of cancer and manage or treat existing cancer diseases. They can also be used with these treatment methods to increase the effectiveness of surgery, chemotherapy, radiotherapy, or targeted therapies applied in the treatment of cancer patients.
The immune system is sensitive, so it is possible to target only cancer cells while protecting healthy cells. Just like cancer, the immune system of living beings can adapt to environmental conditions continuously and dynamically and gain new features. For this reason, even if it manages to evade the detection of defense cells, which is one of the most important features of cancer, the immune system can re-evaluate this situation and initiate a new attack on cancer cells with this new feature. Also, immunotherapies allow the immune system to remember what cancer cells look like (memory cells) so that if cancer cells regenerate, the defense cells can again target and eliminate cancer that has formed without needing any help.
Immunotherapy can be used in diseases such as lung cancer, urinary bladder, lymphoma, colon and rectum, esophagus, head and neck, liver, uterus, melanoma, Merkel cell carcinoma, and squamous cell carcinoma of the skin. In addition, regardless of the organ where the cancer is located, it can be used without the need for any other data if there is a condition such as genetic damage (MSI-H) or the tumor mutation load is high (TMB-H). However, one of the most important concepts to know is that immunotherapy may not always work for every patient.
Certain types of immunotherapies have potentially serious but manageable side effects. The side effects of immunotherapy can often result from stimulation of the immune system, ranging from minor inflammatory reactions and flu-like complaints to major disorders such as self-harm of the body (autoimmune), and potentially life-threatening conditions. Common side effects of immunotherapies include skin reactions (redness, itching), mouth sores, fatigue, nausea, body aches, headaches, and changes in blood pressure.
Radiotherapy, also known as radiation therapy, is a treatment method that aims to eradicate tumor cells with high-energy rays, especially X-rays. It is applied in varying doses and frequencies according to the patients. In the irradiation performed by targeting the tumor, the healthy tissue around the tumor may also be damaged.
Side effects related to radiotherapy mostly develop due to the damage to these healthy tissues and start in the second week after the start of the treatment and continue for 2-3 weeks after the end of the treatment. Although it is not common, it can also cause permanent damage.
When the intact lung tissue around the irradiated tumor is affected, dry cough, fever, and shortness of breath may begin. When these symptoms develop, they should be shared with the relevant doctor. There may be itching and redness on the skin included in the treatment area, and cosmetic products should not be used in the areas included in the irradiation area in order not to increase the damage. Another organ in the chest that will be affected by radiotherapy is the esophagus. Difficulty in swallowing and painful swallowing may develop. Acidic and bitter foods should be avoided during these periods in order not to increase damage to the esophagus. Alcohol and cigarette use should be avoided during the treatment.
In patients with lung cancer, the basal caloric requirement of the body increases due to the increased metabolic activity of the tumor. An increased caloric requirement cannot be met in patients who develop loss of appetite due to chemotherapy and radiotherapy, and rapid weight and muscle loss is observed in patients. The general condition of the patient is very important for treatment success and survival. Determining the total caloric requirement and deficiency of the patients, and supplementing the missing calories, vitamins and minerals increase the patient's quality of life and treatment success and reduce the side effects of chemotherapy.
Nutritional solutions and high protein supplements should be given to patients who receive less than half of the calories they need for more than 10 days, or who are known to be unable to eat for more than a week. In patients with weakened immunity and increased susceptibility to infections during chemotherapy, it is recommended not to consume raw vegetables and fruits without making sure that they are cleaned very well, and to stay away from crowded and closed environments to protect against all infectious diseases during these processes.
Alternative treatment methods such as phytotherapy/herbal product supplementation, which are increasingly used today and are frequently recommended to cancer patients, should not be used without consulting a physician because of the possibility of decreasing the effectiveness of chemotherapy and increasing its toxicity.
During the treatment of lung cancer, general health, and hygiene precautions should be followed carefully, and complaints such as fever, weight loss, yellowing, nausea, and vomiting should be reported to the physician following up with the patient.
”
Alo Yeditepe